The SLC9A3 inhibitor tenapanor for the treatment of hyperphosphatemia in patients with constipated IBS and dialysis chronic kidney disease or end-stage renal disease (Markham, 2019). The gene discussed is SLC9A3; the disease is chronic kidney disease.